Is loss of function of the prion protein the cause of prion disorders?

Trends in Molecular Medicine

Volumn 9, Issue 6, 2003, Pages 237-243

  Hetz, Claudio ^a   Maundrell, Kinsey ^a   Soto, Claudio ^a  

^a SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

DEGENERATIVE DISEASE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRION DISEASE; PROTEIN DEFECT; PROTEIN FOLDING; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0038603947     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(03)00069-8     Document Type: Article

References (61)

1. Collinge, J. (2001) Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24, 519-550
2. Prusiner, S.B. (1998) Prions. Proc. Natl. Acad. Sci. U. S. A. 95, 13363-13383
3. Prusiner, S.B. et al. (1998) Prion protein biology. Cell 93, 337-348
4. Cohen, F.E. and Prusiner, S.B. (1998) Pathologic conformations of prion proteins. Annu. Rev. Biochem. 67, 793-819
5. Budka, H. et al. (1995) Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 5, 459-466
6. Ironside, J.W. et al. (1996) Human prion diseases. J. Neural Transm. 47, 231-246
7. Wells, G.A. (1993) Pathology of nonhuman spongiform encephalopathies: variations and their implications for pathogenesis. Dev. Biol. Stand. 80, 61-69
8. Betmouni, S. et al. (1999) Vacuolation in murine prion disease: an informative artefact. Curr. Biol. 9, R677-R679
9. Gray, F. et al. (1999) Neuronal apoptosis in Creutzfeldt-Jakob disease. J. Neuropathol. Exp. Neurol. 58, 321-328
10. Betmouni, S. et al. (1996) Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience 74, 1-5
11. Ghetti, B. et al. (1996) Prion protein amyloidosis. Brain Pathol. 6, 127-145
12. Jeffrey, M. et al. (1995) Pathology of the transmissible spongiform encephalopathies with special emphasis on ultrastructure. Micron 26, 277-298
13. Harris, D.A. (1999) Cellular biology of prion diseases. Clin. Microbiol. Rev. 12, 429-444
14. Mouillet-Richard, S. et al. (2000) Signal transduction through prion protein. Science 289, 1925-1928
15. C directly interacts with proteins involved in signaling pathways. J. Biol. Chem. 276, 44604-44612
16. Zanata, S.M. et al. (2002) Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J. 21, 3307-3316
17. Smith, D.F. et al. (1993) Identification of a 60-kilodalton stress-related protein, p60, which interacts with hsp90 and hsp70. Mol. Cell. Biol. 13, 869-876
18. Lassle, M. et al. (1997) Stress-inducible, murine protein mSTI1. Characterization of binding domains for heat shock proteins and in vitro phosphorylation by different kinases. J. Biol. Chem. 272, 1876-1884
19. Chiarini, L.B. et al. (2002) Cellular prion protein transduces neuroprotective signals. EMBO J. 21, 3317-3326
20. Forloni, G. et al. (1993) Neurotoxicity of a prion protein fragment. Nature 362, 543-546
21. Selvaggini, C. et al. (1993) Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem. Biophys. Res. Commun. 194, 1380-1386
22. Nguyen, J. et al. (1995) Prion protein peptides induce α-helix to β-sheet conformational transitions. Biochemistry 34, 4186-4192
23. Brown, D.R. et al. (1994) Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment. Neuroreport 5, 2057-2060
24. Kuwahara, C. et al. (1999) Prions prevent neuronal cell-line death. Nature 400, 225-226
25. Gauczynski, S. et al. (2001) Interaction of prion proteins with cell surface receptors, molecular chaperones, and other molecules. Adv. Protein Chem. 57, 229-272
26. Kurschner, C. and Morgan, J.I. (1996) Analysis of interaction sites in homo- and heteromeric complexes containing Bcl-2 family members and the cellular prion protein. Brain Res. Mol. Brain Res. 37, 249-258
27. Bounhar, Y. et al. (2001) Prion protein protects human neurons against Bax-mediated apoptosis. J. Biol. Chem. 276, 39145-39149
28. Flechsig, E. et al. (2000) Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 27, 399-408
29. Brown, D.R. (2001) Copper and prion disease. Brain Res. Bull. 55, 165-173
30. Pattison, I.H. and Jebbett, J.N. (1973) Clinical and histological recovery from the scrapie-like spongiform encephalopathy produced in mice by feeding them with cuprizone. J. Pathol. 109, 245-250
31. Carlton, W.W. (1969) Spongiform encephalopathy induced in rats and guinea pigs by cuprizone. Exp. Mol. Pathol. 10, 274-287
32. Kramer, M.L. et al. (2001) Prion protein binds copper within the physiological concentration range. J. Biol. Chem. 276, 16711-16719
33. Brown, D.R. et al. (1997) The cellular prion protein binds copper in vivo. Nature 390, 684-687
34. Brown, D.R. et al. (1999) Normal prion protein has an activity like that of superoxide dismutase. Biochem. J. 344, 1-5
35. Waggoner, D.J. et al. (2000) Brain copper content and cuproenzyme activity do not vary with prion protein expression level. J. Biol. Chem. 275, 7455-7458
36. Thackray, A.M. et al. (2002) Metal imbalance and compromised antioxidant function are early changes in prion disease. Biochem. J. 362, 253-258
37. Wong, B.S. et al. (2001) Oxidative impairment in scrapie-infected mice is associated with brain metals perturbations and altered antioxidant activities. J. Neurochem. 79, 689-698
38. Wong, B.S. et al. (2001) Aberrant metal binding by prion protein in human prion disease. J. Neurochem. 78, 1400-1408
39. Taraboulos, A. et al. (1992) Synthesis and trafficking of prion proteins in cultured cells. Mol. Biol. Cell 3, 851-863
40. Pauly, P.C. and Harris, D.A. (1998) Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273, 33107-33110
41. Qin, K. et al. (2000) Copper(II)-induced conformational changes and protease resistance in recombinant and cellular PrP. Effect of protein age and deamidation. J. Biol. Chem. 275, 19121-19131
42. Hegde, R.S. et al. (1998) A transmembrane form of the prion protein in neurodegenerative disease. Science 279, 827-834
43. Hegde, R.S. et al. (1999) Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 402, 822-826
44. Sc-like conformation in the cytosol. Science 298, 1785-1788
45. Ma, J. et al. (2002) Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298, 1781-1785
46. Nishitoh, H. et al. (2002) ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev. 16, 1345-1355
47. Rossi, D. et al. (2001) Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO J. 20, 694-702
48. C and its homologue Dpl. Trends Neurosci. 25, 150-154
49. Bueler, H. et al. (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-582
50. Manson, J.C. et al. (1994) 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol. 8, 121-127
51. Sakaguchi, S. et al. (1996) Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380, 528-531
52. Moore, R.C. et al. (1999) Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J. Mol. Biol. 292, 797-817
53. Nicholson, E.M. et al. (2002) Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation. J. Mol. Biol. 316, 807-815
54. Tranulis, M.A. et al. (2001) The PrP-like protein Doppel gene in sheep and cattle: cDNA sequence and expression. Mamm. Genome 12, 376-379
55. Behrens, A. et al. (2002) Absence of the prion protein homologue Doppel causes male sterility. EMBO J. 21, 3652-3658
56. Moore, R.C. et al. (2001) Doppel-induced cerebellar degeneration in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 98, 15288-15293
57. Behrens, A. et al. (2001) Normal neurogenesis and scrapie pathogenesis in neural grafts lacking the prion protein homologue Doppel. EMBO Rep. 2, 347-352
58. Tuzi, N.L. et al. (2002) Expression of doppel in the CNS ofmice does not modulate transmissible spongiform encephalopathy disease. J. Gen. Virol. 83, 705-711
59. Shmerling, D. et al. (1998) Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93, 203-214
60. Mallucci, G.R. et al. (2002) Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J. 21, 202-210
61. Brown, D.R. et al. (2002) Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J. Neurosci. Res. 67, 211-224